These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29130961)

  • 21. Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.
    Bulut D; Becker V; Mügge A
    Can J Physiol Pharmacol; 2011 Apr; 89(4):239-44. PubMed ID: 21539467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial.
    Lundwall K; Mörtberg J; Mobarrez F; Jacobson SH; Jörneskog G; Spaak J
    BMC Nephrol; 2019 Aug; 20(1):290. PubMed ID: 31370809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea.
    Sun H; Fang F; Li K; Zhang H; Zhang M; Zhang L; Li J; Qin Y; Wei Y
    Respir Res; 2019 Aug; 20(1):188. PubMed ID: 31429753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis.
    Philippova M; Suter Y; Toggweiler S; Schoenenberger AW; Joshi MB; Kyriakakis E; Erne P; Resink TJ
    Eur Heart J; 2011 Mar; 32(6):760-71. PubMed ID: 20584775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular dysfunction in obstructive sleep apnoea: Implication of microparticules].
    Trzepizur W; Priou P; Meslier N; Urban T; Martínez MC; Andriantsitohaina R; Gagnadoux F
    Rev Pneumol Clin; 2017 Dec; 73(6):306-308. PubMed ID: 29126756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
    Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism.
    Jansen F; Yang X; Baumann K; Przybilla D; Schmitz T; Flender A; Paul K; Alhusseiny A; Nickenig G; Werner N
    J Cell Mol Med; 2015 Sep; 19(9):2202-14. PubMed ID: 26081516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules.
    Cheng Q; McKeown SJ; Santos L; Santiago FS; Khachigian LM; Morand EF; Hickey MJ
    J Immunol; 2010 Jul; 185(2):1238-47. PubMed ID: 20554956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
    Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
    Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction.
    Radecke CE; Warrick AE; Singh GD; Rogers JH; Simon SI; Armstrong EJ
    Thromb Haemost; 2015 Mar; 113(3):605-16. PubMed ID: 25413339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
    Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV
    Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Christersson C; Thulin Å; Siegbahn A
    Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
    Montoro-García S; Shantsila E; Tapp LD; López-Cuenca A; Romero AI; Hernández-Romero D; Orenes-Piñero E; Manzano-Fernández S; Valdés M; Marín F; Lip GY
    Atherosclerosis; 2013 Apr; 227(2):313-22. PubMed ID: 23415055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597).
    Teoh NC; Ajamieh H; Wong HJ; Croft K; Mori T; Allison AC; Farrell GC
    PLoS One; 2014; 9(9):e104376. PubMed ID: 25222287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
    Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
    Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
    Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
    Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
    Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.
    Neves KB; Rios FJ; Jones R; Evans TRJ; Montezano AC; Touyz RM
    Cardiovasc Res; 2019 Apr; 115(5):978-988. PubMed ID: 30753341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation.
    Morel O; Pereira B; Averous G; Faure A; Jesel L; Germain P; Grunebaum L; Ohlmann P; Freyssinet JM; Bareiss P; Toti F
    Atherosclerosis; 2009 Jun; 204(2):636-41. PubMed ID: 19091315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.